Tao, D. L., Abdel-Wahab, R., Lin, R., Daher, M., Liu, B., Basar, R., Shpall, E. J., Rezvani, K., Diab, A. (2025). Phase I dose escalation and expansion study of PRAME T-cell receptor (TCR) engineered IL15-transduced cord blood–derived natural killer (NK) cells in patients with recurrent and/or refractory melanoma (PRAMETIME-Mel).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps9602